Helix BioPharma Corp. (HBPCF)
OTCMKTS
· Delayed Price · Currency is USD
1.734
+1.134 (189.00%)
At close: Oct 22, 2025
Helix BioPharma Employees
Helix BioPharma had 7 employees as of July 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-$537,282
Market Cap
128.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Helix BioPharma News
- 5 weeks ago - Helix Biopharma GAAP EPS of -$0.09 - Seeking Alpha
- 5 weeks ago - Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results - TheNewswire
- 2 months ago - Helix BioPharma Responds to Market Activity - TheNewswire
- 3 months ago - Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025 - TheNewswire
- 3 months ago - Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM - TheNewswire
- 3 months ago - Helix Biopharma Corp. Announces Closing of Private Placement, in Preparation for Institutional Investment and NASDAQ Uplisting - TheNewswire
- 4 months ago - Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC - TheNewswire
- 6 months ago - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025 - TheNewswire